FDA Approved: FLUDEOXYGLUCOSE F 18 — Supplemental Application (Massachusetts General Hospital)

View source ↗

Summary

FDA approved a supplemental application for Fludeoxyglucose F-18 submitted by Massachusetts General Hospital to support its use as a radiopharmaceutical for PET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cancer
• Cardiovascular Disease
• Dementia
• Ischemic Heart Disease

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

SUPPL AP for FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F-18)